Antimicrobial stewardship: English Surveillance Programme for Antimicrobial Utilization and Resistance (ESPAUR)
Authors:
- D. Ashiru-OredopeD. Ashiru-Oredope
- Susan Hopkins on behalf of the English Surveillance Programme for Antimicrobial Utilization and Resistance Oversight GroupSGSusan Hopkins on behalf of the English Surveillance Programme for Antimicrobial Utilization and Resistance Oversight Group
- Susan HopkinsSHSusan Hopkins
Open Access
- 11 September 2013
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Antimicrobial Chemotherapy
- Vol. 68 (11) , 2421-2423
Abstract
The clinical, public health and economic implications of antimicrobial resistance present a major threat to future healthcare. Antimicrobial use is a major driver of resistance, and antimicrobial stewardship programmes are increasingly being advocated as a means of improving the quality of prescribing. However, to increase their impact and assess their success, a better understanding of antimicrobial usage, both in primary and secondary care, and linkage with antimicrobial resistance data are required. In England, national summaries of primary care dispensing data are issued annually by the Health and Social Care Information Centre. However, there is currently no routine public reporting of antimicrobial usage in hospitals. In response to the threat posed by antimicrobial resistance, as highlighted in the Report of the Chief Medical Officer and on the request of the Department of Health, Public Health England has developed a new national programme, the English Surveillance Programme for Antimicrobial Utilization and Resistance (ESPAUR). The programme will bring together the elements of antimicrobial utilization and resistance surveillance in both primary and secondary care settings, alongside the development of quality measures and methods to monitor unintended outcomes of antimicrobial stewardship and both public and professional behaviour interventions. This article reports on the background to the programme development, the current oversight group membership and the public reporting structure.Keywords
This publication has 12 references indexed in Scilit:
- Declining cephalosporin and fluoroquinolone non-susceptibility among bloodstream Enterobacteriaceae from the UK: links to prescribing change?Journal of Antimicrobial Chemotherapy, 2013
- Mermel LA (Clin Infect Dis 2013; 56:123-30)Clinical Infectious Diseases, 2013
- The true cost of antimicrobial resistanceBMJ, 2013
- European Antibiotic Awareness Day 2012: TARGET antibiotics through guidance, education, and toolsBritish Journal of General Practice, 2012
- Improving the quality of antibiotic prescribing in the NHS by developing a new Antimicrobial Stewardship Programme: Start Smart--Then FocusJournal of Antimicrobial Chemotherapy, 2012
- Behavior Change Strategies to Influence Antimicrobial Prescribing in Acute Care: A Systematic ReviewClinical Infectious Diseases, 2011
- Antibiotic prescribing in hospitals: a social and behavioural scientific approachThe Lancet Infectious Diseases, 2010
- Uncomfortable prescribing decisions in hospitals: the impact of teamworkJournal of the Royal Society of Medicine, 2009
- New medicines in primary care: a review of influences on general practitioner prescribingJournal of Clinical Pharmacy and Therapeutics, 2008
- Prior antibiotics and risk of antibiotic-resistant community-acquired urinary tract infection: a case–control studyJournal of Antimicrobial Chemotherapy, 2007